Inclusion and diversity in the PRINCIPLE trial by Patel, MG, Dorward, J, Yu, L-M, Hobbs, FDR, Butler, CC

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, ad... by PRINCIPLE Trial Collaborative Group, Butler, CC, Dorward, J, Yu, L-M, Gbinigie, O, Hayward, G, Saville, BR, Van Hecke, O, Berry, N, Detry, M, Saunders, C, Fitzgerald, M, Harris, V, Patel, MG, De Lusignan, S, Ogburn, E, Evans, PH, Thomas, NPB, Hobbs, FDR

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform... by Butler, CC, Yu, L-M, Dorward, J, Gbinigie, O, Hayward, G, Saville, BR, Van Hecke, O, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Djukanovic, R, Gadola, S, Kirkpatrick, J, Ogburn, E, Patel, MG, de Lusignan, S, Evans, PH, Thomas, NPB, Hobbs, FDR

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial by Yu, L-M, Bafadhel, M, Dorward, JJ, Hayward, G, Saville, BR, Gbinigie, O, Van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Richards, D, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Shanyinde, M, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Ramakrishnan, S, Hobbs, FDR, Butler, CC, Yu, L-M, Bafadhel, M, Dorward, J, Hayward, G, Saville, BR, Gbinigie, O, van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Richards, D, Berry, N, Detry, MA, Saunders, CT, Fitzgerald, M, Harris, V, Shanyinde, M, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Ramakrishnan, S

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial by Yu, L-M, Ramakrishnan, S, Bafadhel, M, Dorward, J, Hayward, G, Saville, BR, Gbinigie, O, van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Berry, N, Detry, MA, Saunders, CT, Fitzgerald, M, Harris, V, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Hobbs, FDR, Butler, CC

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes by Hayward, G, Yu, L-M, Little, P, Gbinigie, O, Shanyinde, M, Harris, V, Dorward, J, Saville, BR, Berry, N, Evans, PH, Thomas, NP, Patel, MG, Richards, D, van Hecke, O, Detry, MA, Saunders, C, Fitzgerald, M, Robinson, J, Latimer-Bell, C, Allen, J, Ogburn, E, Grabey, J, de Lusignan, S, Hobbs, FR, Butler, CC

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive... by Butler, CC, Hobbs, FDR, Gbinigie, OA, Rahman, NM, Hayward, G, Richards, DB, Dorward, J, Lowe, DM, Standing, JF, Breuer, J, Khoo, S, Petrou, S, Hood, K, Nguyen-Van-Tam, JS, Patel, MG, Saville, BR, Marion, J, Ogburn, E, Allen, J, Rutter, H, Francis, N, Thomas, NPB, Evans, P, Dobson, M, Madden, T-A, Holmes, J, Harris, V, Png, ME, Lown, M, van Hecke, O, Detry, MA, Saunders, CT, Fitzgerald, M, Berry, NS, Mwandigha, L, Galal, U, Mort, S, Jani, BD, Hart, ND, Ahmed, H, Butler, D, McKenna, M, Chalk, J, Lavallee, L, Hadley, E, Cureton, L, Benysek, M, Andersson, M, Coates, M, Barrett, S, Bateman, C, Davies, JC, Raymundo-Wood, I, Ustianowski, A, Carson-Stevens, A, Yu, L-M, Little, P